Physician profile
Sheena E Cox
NPI 1437518982
$1,694.82
in general payments reported to CMS, 2019-2025
16 companies · $601 in 2025
The $601 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $101 · 2022: $56.44 · 2023: $327 · 2024: $610 · 2025: $601.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,537.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $319.15 | 2021-2024 | |
| Novo Nordisk INC | $247.61 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Astellas Pharma US INC | $221.12 | 2023-2025 | Veozah |
| Astrazeneca Pharmaceuticals Lp | $193.73 | 2024-2025 | Farxiga, Airsupra |
| Exact Sciences Corporation | $129.74 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Medtronic, INC. | $111.94 | 2024 | Kyphon Express II Kyphopak Tray |
| Lilly USA, LLC | $102.96 | 2023-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $87.59 | 2023-2024 | |
| Dexcom, INC. | $73.35 | 2024-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $56.17 | 2024-2025 | Gvoke Hypopen |
| Amgen INC. | $43.84 | 2023-2025 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $33.22 | 2024 | |
| Mylan Specialty L.P. | $22.82 | 2023 | Yupelri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.93 | 2024 | Xifaxan, Trulance |
| Axsome Therapeutics, INC. | $16.87 | 2025 | Auvelity |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $13.78 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheena Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.